Category: Benzisoxazole

Some examples of the diverse research done by chemistry experts include discovery of new medicines and vaccines, improving understanding of environmental issues, and development of new chemical products and materials. In a document, author is Chauhan, Jay, introducing its new discovery. Synthetic Route of 98-89-5.

One-pot synthesis of 2,1-benzisoxazoles (anthranils) by a stannous chloride-mediated tandem reduction-heterocyclization of 2-nitroacylbenzenes under neutral conditions

Classically, 2,1-benzisoxazoles (anthranils) are prepared from 2-nitroacylbenzenes by a reductive heterocyclization reaction with Sn or SnCl2 concentrated HCl. Acid sensitive functionalities are expected to be incompatible with these conditions; milder approaches to the synthesis of 2,1-benzisoxazoles would be welcomed. We demonstrate that SnCl2 center dot 2H(2)O in a 1:1 mixture of EtOAc/MeOH is capable of mediating the tandem reduction-heterocyclization of a variety of 2-nitroacylbenzenes to their corresponding 2,1-benzisoxazoles in good to excellent yields under essentially neutral conditions. Importantly, several commonly used acid-labile protecting groups, including Boc carbamate, tert-butyl ether, and tert-butyl ester, proved orthogonal to these reaction conditions. (C) 2012 Elsevier Ltd. All rights reserved.

If you are interested in 98-89-5, you can contact me at any time and look forward to more communication. Synthetic Route of 98-89-5.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

Academic researchers, R&D teams, teachers, students, policy makers and the media all rely on us to share knowledge that is reliable, accurate and cutting-edge. 719-64-2, Name is 5-Chloro-3-phenylbenzo[c]isoxazole, formurla is C13H8ClNO. In a document, author is Arava, Veera Reddy, introducing its new discovery. SDS of cas: 719-64-2.

Novel base catalysed rearrangement of sultone oximes to 1,2-benzisoxazole-3-methane sulfonate derivatives

A new process for the preparation of 1,2-benzisoxazole-3-methanesulfonates and 4-oximino-2,3dihydrobenzoxathiin- 2,2-dioxides (sultone oximes) is described. These compounds are important intermediates for the preparation of zonisamide, an anti-convulsant drug.

SDS of cas: 719-64-2, We very much hope you enjoy reading the articles and that you will join us to present your own research about 719-64-2.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

Research speed reading in 2021. Chemistry, like all the natural sciences, begins with the direct observation of nature— in this case, of matter. Formula: https://www.ambeed.com/products/15026-17-2.html, The reactant in an enzyme-catalyzed reaction is called a substrate. Enzyme inhibitors cause a decrease in the reaction rate of an enzyme-catalyzed reaction. 15026-17-2, Name is 4-(tert-Butoxy)-4-oxobutanoic acid, molecular formula is C8H14O4. In an article, author is Weyland, M.,once mentioned of 15026-17-2.

Artificial enzymes based on imprinted liquid-crystalline materials

Liquid-crystal elastomers, imprinted around indole, are assessed as artificial enzymes for the isomerisation of benzisoxazole into 2-cyano phenol. Two types of material are synthesised, tested in the catalysis and compared with non-liquid-crystal imprinted polymers: an imprinted liquid-crystalline elastomer and a semi-interpenetrated imprinted liquid-crystal network. The catalytic effect of all materials is close. However, the main benefit for the liquid-crystal elastomer is shown to be the shape memory of the material at the molecular scale, because the isomerisation kinetics are found to be identical before and after deformation of the cavities either by thermal treatment up to the isotropic state or by solvent induced swelling. This fact is related to the coupling between the order and the conformation of the polymer chains, which is fixed by the crosslinking process. On the other hand, the imprinted sites of the semi-interpenetrated imprinted liquid-crystal elastomer are shown to be almost 100 times more active than the non-imprinted sites in the catalysis. This factor is only 22 for the corresponding non-liquid-crystalline network.

I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 15026-17-2 help many people in the next few years. Formula: https://www.ambeed.com/products/15026-17-2.html.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

New Advances in Chemical Research in 2021. Irreversible inhibitors are therefore the equivalent of poisons in heterogeneous catalysis. 79-14-1, Name is 2-Hydroxyacetic acid, molecular formula is C2H4O3, Category: Benzisoxazole, belongs to benzisoxazole compound, is a common compound. In a patnet, author is Okada, M, once mentioned the new application about 79-14-1.

Effects of zonisamide on dopaminergic system

Effects of zonisamide (ZNS) on extracellular dopamine (DA), its precursor 3,4-dihydroxyphenylalanine (DOPA), its metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) levels in the striatum as well as hippocampus of freely moving rats were studied. Intracellular DA, DOPA, DOPAC and HVA levels, as well as DOPA accumulation as an index of tyrosine hydroxylase activity in the rat brain in vivo, DA re-uptake in the striatum and hippocampus, and monoamine oxidase (MAO) activities were also determined. Acute administrations of therapeutic ZNS doses (20 and 50 mg/kg) increased striatal extracellular DOPA levels, intracellular striatal and hippocampal DOPA levels, and stimulated DOPA accumulation in both brain regions. ZNS also increased striatal and hippocampal intracellular as well as extracellular DA and MIA Levels, but decreased those of DOPAC levels. Chronic (3 weeks) administrations of therapeutic ZNS doses (20 and 50 mg/kg/day) increased intracellular DA, DOPA, DOPAC and HVA levels in striatum and hippocampus. ZNS-induced changes were greater in intracellular levels than in extracellular levels. Acute and chronic supratherapeutic ZNS dose (100 mg/kg) administration decreased intracellular levels of all substances detectable in both brain regions, and inhibited DOPA accumulation. Both subtypes of MAO (type A and type B) activities were weakly inhibited by ZNS. ZNS showed no effect on DA re-uptake in striatum nor in hippocampus. These results suggest that therapeutic ZNS doses increase DOPA accumulation as well as both intracellular and extracellular DA, DOPA and HVA levels. However, such doses also decrease extracellular and intracellular DOPAC levels by enhancing DA synthesis and/or by selectively inhibiting MAO-B activities. In addition, chronic therapeutic ZNS dose administration enhances DA synthesis, which results in increased intracellular DA, its precursor and its metabolites levels. On the other hand, both acute and chronic supratherapeutic ZNS dose administrations inhibit DA turnover. These ZNS effects on DA metabolism are at least partly involved in the mechanisms of action of ZNS.

You can get involved in discussing the latest developments in this exciting area about 79-14-1, Category: Benzisoxazole.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

Chemical engineers ensure the efficiency and safety of chemical processes, adapt the chemical make-up of products to meet environmental or economic needs, and apply new technologies to improve existing processes. 503-66-2, Name is 3-Hydroxypropionic Acid (contains varying amounts of 3,3-Oxydipropionic Acid), molecular formula is C3H6O3, Application In Synthesis of 3-Hydroxypropionic Acid (contains varying amounts of 3,3-Oxydipropionic Acid), belongs to benzisoxazole compound, is a common compound. In a patnet, author is Zhang, Xiaofeng, once mentioned the new application about 503-66-2.

One-pot and catalyst-free synthesis of pyrroloquinolinediones and quinolinedicarboxylates

A method for the catalyst-free synthesis of pyrroloquinolinediones and quinolinedicarboxylates is developed through a one-pot synthesis involving denitrogenation of azide, benzisoxazole formation, aza-Diels-Alder cycloaddition, and dehydrative aromatization. Only stoichiometric amounts of N-2 and H2O are produced as by-products. A comprehensive green chemistry metrics analysis indicated that this method is much more efficient and greener than two reported methods for the synthesis of pyrroloquinolinediones.

Application In Synthesis of 3-Hydroxypropionic Acid (contains varying amounts of 3,3-Oxydipropionic Acid), We very much hope you enjoy reading the articles and that you will join us to present your own research about 503-66-2.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

When developing chemical systems it’s of course important to gain a deep understanding of the chemical reaction process. 719-64-2, Name is 5-Chloro-3-phenylbenzo[c]isoxazole, SMILES is ClC1=CC2=C(C3=CC=CC=C3)ON=C2C=C1, in an article , author is Ikeda, Ryuhei, once mentioned of 719-64-2, Category: Benzisoxazole.

Catalytic Asymmetric Hydrogenation of 3-Substituted Benzisoxazoles

A variety of 3-substituted benzisoxazoles were reduced with hydrogen using the chiral ruthenium catalyst, {RuCl(p-cymene)[(R,R)-(S,S)-PhTRAP]}Cl. The ruthenium-catalyzed hydrogenation proceeded in high yield in the presence of an acylating agent, affording alpha-substituted o-hydroxybenzylamines with up to 57% ee. In the catalytic transformation, the N-O bond of the benzisoxazole substrate is reductively cleaved by the ruthenium complex under the hydrogenation conditions. The C-N double bond of the resulting imine is saturated stereoselectively through the PhTRAP-ruthenium catalysis. The hydrogenation produces chiral primary amines, which may work as catalytic poisons, however, the amino group of the hydrogenation product is rapidly acylated when the reaction is conducted in the presence of an appropriate acylating agent, such as Boc(2)O or Cbz-OSu.

Interested yet? Read on for other articles about 719-64-2, you can contact me at any time and look forward to more communication. Category: Benzisoxazole.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

Chemistry graduates have much scope to use their knowledge in a range of research sectors, including roles within chemical engineering, chemical and related industries, healthcare and more. 6106-21-4, Name is Sodium succinate hexahydrate, SMILES is O=C([O-])CCC([O-])=O.[H]O[H].[H]O[H].[H]O[H].[H]O[H].[H]O[H].[H]O[H].[Na+].[Na+], in an article , author is MIMAKI, T, once mentioned of 6106-21-4, Reference of 6106-21-4.

REGIONAL DISTRIBUTION OF C-14 ZONISAMIDE IN RAT-BRAIN

Zonisamide (1,2-benzisoxazole-3-methane sulfonamide) is a new antiepileptic drug developed in Japan. This compound was proven to possess a strong inhibitory effect on convulsions of cortical origin, whether induced by electric or chemical stimuli, Regional distribution of C-14-zonisamide was investigated in rat brain using autoradiography. A high uptake of C-14 activity was observed in the cerebral cortex and the midbrain. A pair-match analysis of primary motor cortex versus primary sensory cortex revealed a slightly higher uptake in primary motor cortex. In the cerebellum, a higher uptake was observed in the cortex than medulla. Sagittal section analyses revealed that a high uptake of C-14 activity was observed in the cerebral cortex and colliculus, and a moderate uptake was seen in the cerebellum, thalamus, hypothalamus, and striatal body, thus suggesting the distribution of C-14-zonisamide is similar to that of flunitrazepam and phenytoin.

But sometimes, even after several years of basic chemistry education, it is not easy to form a clear picture on how they govern reactivity! 6106-21-4, you can contact me at any time and look forward to more communication. Reference of 6106-21-4.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

Healthcare careers for chemists are once again largely based in laboratories, although increasingly there is opportunity to work at the point of care, helping with patient investigation. 843666-40-0, Name is 18-(tert-Butoxy)-18-oxooctadecanoic acid, SMILES is O=C(O)CCCCCCCCCCCCCCCCC(OC(C)(C)C)=O, in an article , author is Brinchi, Lucia, once mentioned of 843666-40-0, Quality Control of 18-(tert-Butoxy)-18-oxooctadecanoic acid.

Accelerated decarboxylation of 6-nitrobenzisoxazole-3-carboxylate in imidazolium-based ionic liquids and surfactant ionic liquids

We report the use of the unimolecular, spontaneous decarboxylation of 6-nitrobenzisoxazole-3-carboxylate, 6-NBIC, as kinetic probe to investigate the properties of aqueous solutions of a series of ILs, 1-alkyl-3-methyl imidazolium derivatives. The ILs are denoted as [C(4)mim][X], where n indicates the number of carbon atoms in 1-alkyl chain. We studied [C(4)mim][Cl] with X = Cl-, Br-, and BF4-, and the surface-active ILs, SAILs, [C(12)mim][Cl], [C(12)mim][Br], and [C(16)mim][Br]. For comparison purposes we also studied nonmicellizing tetrallcylammonium chloride and bromide, denoted as TRAX, where R is alkyl group and X the anion. We observed a steep increase of values of k(obs) after a certain salt concentration for all the systems used. Electrical conductivity of various aqueous systems was measured, in an attempt to rationalize the kinetic effects. Data from conductivity and kinetic are consistent with the idea that after a certain, high, concentration aggregates of ILs form, and data from the kinetics suggest that water is someway squeezed out from these aggregates. As can be deduced from kinetics, properties of the aggregates formed by [C4mim][X] ILs correlate well with bulk water structure affecting properties of the salts, and seem to have no relation to surface effects. (C) 2010 Elsevier Inc. All rights reserved.

Do you like my blog? If you like, you can also browse other articles about this kind. Thanks for taking the time to read the blog about 843666-40-0, Quality Control of 18-(tert-Butoxy)-18-oxooctadecanoic acid.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

Career opportunities within science and technology are seeing unprecedented growth across the world, and those who study chemistry or another natural science at university now have increasingly better career prospects. In a document, author is Jimena Prieto, Maria, introducing its new discovery. Recommanded Product: 2-[1-(2-Amino-2-oxoethyl)cyclohexyl]acetic Acid.

Optimization and In Vivo Toxicity Evaluation of G4.5 Pamam Dendrimer-Risperidone Complexes

Risperidone is an approved antipsychotic drug belonging to the chemical class of benzisoxazole. This drug has low solubility in aqueous medium and poor bioavailability due to extensive first-pass metabolism and high protein binding (>90%). Since new strategies to improve efficient treatments are needed, we studied the efficiency of anionic G4.5 PAMAM dendrimers as nanocarriers for this therapeutic drug. To this end, we explored dendrimer-risperidone complexation dependence on solvent concentration, pH and molar relationship. The best dendrimer-risperidone incorporation (46 risperidone molecules per dendrimer) was achieved with a mixture of chloroform: methanol 50:50 v/v solution pH 3. In addition, to explore the possible effects of this complex, in vivo studies were carried out in the zebrafish model. Changes in the development of dopaminergic neurons and motoneurons were studied using tyrosine hydroxylase and calretinin, respectively. Physiological changes were studied through histological sections stained with hematoxylin-eosin to observe possible morphological brain changes. The most significant changes were observed when larvae were treated with free risperidone, and no changes were observed when larvae were treated with the complex.

If you are hungry for even more, make sure to check my other article about 99189-60-3, Recommanded Product: 2-[1-(2-Amino-2-oxoethyl)cyclohexyl]acetic Acid.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

Chemistry, like all the natural sciences, begins with the direct observation of nature— in this case, of matter. 868-14-4, Name is Potassium hydrogen tartrate, SMILES is [O-]C(C(C(C(O)=O)O)O)=O.[K+], in an article , author is Kim, HL, once mentioned of 868-14-4, Application of 868-14-4.

Clinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral center

We evaluated our clinical experience with zonisamide, a broad-spectrum antiepileptic drug, in a group of children with predominantly medically refractory epilepsy. A retrospective chart review was conducted on patients at our tertiary referral center following Institutional Review Board approval. Observers documented reports of seizure frequency, and seizure types were identified either clinically or by prior video-electroencephalography monitoring. We identified 68 patients (age range 1.9-18.1 years [median 6.9 years]; male to female ratio 1.3:1) treated with zonisamide for 0.7 to 28.9 months; at the last visit, 22% and 78% were on monotherapy and adjunctive therapy, respectively. The median duration of treatment and maintenance dose at the end of the follow-up were 11.2 months and 8.0 mg/kg/day, respectively. Seizure types included generalized (primary generalized tonic-clonic, myoclonic, tonic, atonic, absence) and partial (simple, complex, and secondarily generalized tonic-clonic seizures); 10 (15%) patients had both partial and generalized seizures. Sixteen (25.8%) patients were seizure free, although five of them were already in remission prior to starting zonisamide. Thirteen (21.0%) patients had a >= 50% seizure reduction, 10 (16.1%) patients had a < 50% seizure reduction, 14 (22.6%) had no improvement in baseline seizures, and 9 (14.5%) reported having increased seizures. The latter were mostly associated with dosage alterations in concomitant antiepileptic drugs. Common side effects were central nervous system related, including behavioral or psychiatric (23.5%), cognitive dysfunction (12.0%), and sedation (10.3%). Eleven (16.2%) patients ultimately discontinued zonisamide, but only five were strictly due to side effects. Zonisamide is clinically effective against multiple seizure types in a significant proportion of children with epilepsy across a broad age range. Drug discontinuation as a result of side effects is uncommon. Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law. In my other articles, you can also check out more blogs about 868-14-4. Application of 868-14-4.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics